Advanced Triple Negative Breast Cancer (TNBC) With High TAMs
1 clinical trials · Condition
◉ Watch Advanced Triple Negative Breast Cancer (TNBC) With High TAMs
| Record | Firm | Date |
|---|---|---|
| Efficacy Study of MCS110 Given With Carboplatin and Gemcitabine in Advanced Triple Negative Breast Cancer (TNBC) (NCT02435680) | Novartis Pharmaceuticals | 2015-08-10 |
Track Advanced Triple Negative Breast Cancer (TNBC) With High TAMs automatically
Every clearance here is in the API, with alerts when new ones post.